Changing the Game in
Drug Development and Patient Access

Model-informed Drug Development
Health Economics/Outcomes Research & Real World Evidence
Regulatory Science, Strategy & Services

Certara Launches Version 8.1 of Industry-leading Phoenix PK/PD M&S Software; Introduces Professional Certification Program

Certara Acquires Pirana™, a Leading Pharmacometrics Workbench

Certara Software or Services Supported 95% of the US FDA Novel Drug Approvals in First Half of 2018

FDA Renews and Expands its Portfolio of Simcyp Simulator Licenses

Increased Use of PBPK Modeling and Simulation is a Priority in Both the Prescription Drug User Fee Act and Generic Drug User Fee Amendments

Our Mission

Enable superior drug development and patient care decision-making through model-informed drug development, regulatory science, real world evidence and knowledge integration, thus optimizing R&D productivity, commercial value and patient outcomes.

Latest from Certara

Blog

In the Press

Webinars